| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.51 | 0.09 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.06 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |